Sökning: onr:"swepub:oai:DiVA.org:oru-101599" >
Testosterone concen...
Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial
-
- Nilsson, Erik, 1975- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
-
- Stenvinkel, Peter (författare)
- Karolinska Institutet
-
- Liu, Sai (författare)
- Division of Nephrology, Department of Medicine, Stanford University School of Medicine, USA
-
visa fler...
-
- Stedman, Margaret R. (författare)
- Division of Nephrology, Department of Medicine, Stanford University School of Medicine, USA
-
- Chertow, Glenn M. (författare)
- Division of Nephrology, Department of Medicine, Stanford University School of Medicine, USA
-
- Floege, Jürgen (författare)
- Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany
-
visa färre...
-
(creator_code:org_t)
- 2022-09-29
- 2023
- Engelska.
-
Ingår i: Nephrology, Dialysis and Transplantation. - : Oxford University Press. - 0931-0509 .- 1460-2385. ; 38:6, s. 1519-1527
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Hypogonadism is common in end-stage kidney disease and may contribute to morbidity and mortality.METHODS: Using data from the randomized controlled EVOLVE trial of cinacalcet, we analyzed the associations of total testosterone, free testosterone, and sex-hormone binding globulin (SHBG) serum concentrations with mortality and major cardiovascular events in 1692 men and 1059 women receiving hemodialysis. We also describe the effect of cinacalcet treatment on serum concentrations of testosterone.RESULTS: Among men, lower serum free testosterone (OR 0.18 95%, CI 0.04-0.82, p = 0.026) and higher SHBG (OR 1.05 per 10 nmol/L, 95% CI 1.01-1.10, p = 0.012), but not total testosterone, were associated with higher risk of death or cardiovascular event. Only SHBG was associated with all-cause mortality (OR 1.07 per 10 nmol/L, 95% CI 1.02-1.12, p = 0.0073). Among women, neither total- or free testosterone, nor SHBG were associated with outcomes. We found no statistically significant effect of cinacalcet treatment on SHBG, free- or total testosterone.CONCLUSIONS: Lower free testosterone and higher SHBG in serum are associated with higher risk of death or cardiovascular event in men undergoing chronic hemodialysis.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Cardiovascular disease
- hemodialysis
- mortality
- testosterone
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas